Skip to main content
. Author manuscript; available in PMC: 2020 Sep 9.
Published in final edited form as: JAMA. 2016 Jan 26;315(4):362–370. doi: 10.1001/jama.2015.18589

Table 1.

Baseline Characteristics of Mothers Participating in the Vitamin D Antenatal Asthma Reduction Trial (N = 876)

No. (%) of Participants
4400 IU/d of Vitamin D (n = 440) 400 IU/d of Vitamin D (n = 436)
Age, mean (SD), y 27.5 (5.5) 27.3 (5.6)
Gestation age, mean (SD), wk 14.1 (2.8) 14.2 (2.7)
25-Hydroxyvitamin D, mean (SD), ng/mLa 23.3 (10.1) 22.5 (10.1)
Mother
 Asthma 191 (43) 167 (38)
 Allergic rhinitis 275 (63) 283 (65)
 Eczema 139 (32) 139 (32)
Maternal partner
 Asthma 108 (25) 94 (22)
 Allergic rhinitis 173 (39) 192 (44)
 Eczema 81 (18) 63 (14)
Mother’s race/ethnicity
 Black 190 (43) 190 (44)
 White Hispanic 59 (13) 61 (14)
 White non-Hispanic 114 (26) 116 (27)
 Other 77 (18) 69 (16)
Educational status
 <High school 66 (15) 42 (10)
 High school or technical school 123 (28) 142 (33)
 Some college 108 (25) 105 (24)
College graduate or graduate school 143 (33) 147 (34)
Marital status
 Married 191 (43) 203 (47)
 Divorced or separated 13 (3) 10 (2)
 Not married 236 (54) 223 (51)
Household income, US $
 <30 000 132 (30) 128 (29)
 30 000–49 999 62 (14) 58 (13)
 50 000–74 999 50 (11) 51 (12)
 75 000–99 999 42 (10) 39 (9)
 100 000–149 000 35 (8) 36 (8)
 >150 000 18 (4) 14 (3)
Refused to say or unknown 101 (23) 110 (25)

SI conversion factor: To convert 25-hydroxyvitamin D from ng/mL to nmol/L, multiply by 2.496.

a

The 4400 vitamin D IU group included 437 women; 400 vitamin D IU group, 433 women.